Metastatic Small Cell Neuroendocrine Carcinoma
1 clinical trials · Condition
◉ Watch Metastatic Small Cell Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors (NCT04079712) | National Cancer Institute (NCI) | 2020-08-06 |
Track Metastatic Small Cell Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.